NCT04065243

Brief Summary

The objective of this study is to determine the homeostatic mechanisms that counteract weight gain in response to experimental overfeeding.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 22, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

August 22, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

3.4 years

First QC Date

August 8, 2019

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in blood protein patterns using proteomics 1 week before, during 2 weeks of overfeeding and 2 weeks after overfeeding

    Blood will be collected for proteomics at screening, at baseline, during the overfeeding intervention and during the 2-week ad libitum intervention. Samples will be measured using LCMS instrumentation consisting of a nanoelectrospray ion source to a Q Exactive HF mass spectrometer.

    5 weeks

  • Changes in blood peptide patterns using peptidomics 1 week before, during 2 weeks of overfeeding and 2 weeks after overfeeding

    Blood will be collected for peptidomics at screening, at baseline, during the overfeeding intervention and during the 2-week ad libitum intervention. Samples will be measured using LCMS instrumentation consisting of a nanoelectrospray ion source to a Q Exactive HF mass spectrometer.

    5 weeks

Secondary Outcomes (9)

  • Body weight

    5 weeks

  • Fat biopsy from subcutaneous adipose tissue before and after 2 weeks of overfeeding

    2 weeks

  • Microdialysate from subcutaneous adipose tissue before and after 2 weeks of overfeeding. The samples will be used for detection of known and unknown secreted factors

    2 weeks

  • Body composition in 40 subjects before and after overfeeding

    3 weeks

  • Mixed meal test

    2 weeks

  • +4 more secondary outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

Subjects in this group will have a daily energy intake equivalent of 100 % of their calculated normal daily energy intake.

Other: Isocaloric diet

Overfed group

EXPERIMENTAL

Subjects in this group will have a daily energy intake equivalent of 150 % of their calculated normal daily energy intake.

Other: Overfeeding diet

Interventions

Two weeks of overfeeding

Overfed group

Two weeks of isocaloric weight maintenance

Control group

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female otherwise healthy subjects
  • years of age
  • BMI (Body mass index) between 22-30 kg/m2

You may not qualify if:

  • Present or previous cardiovascular disease, diabetes or thyroid-disease
  • smoking
  • more than 3 hours of planned physical activity per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen

Copenhagen, Norrebro, 2200, Denmark

Location

MeSH Terms

Conditions

OvernutritionObesity

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesOverweightBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Christoffer Clemmensen, Assoc. Prof.

    Assoc. prof. NNF Center for Basic Metabolic Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Body weight and other anthropometric data are not masked.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 8, 2019

First Posted

August 22, 2019

Study Start

August 22, 2019

Primary Completion

January 1, 2023

Study Completion

January 1, 2023

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations